GenSight Biologics S.A.

GenSight Biologics S.A.verified

SIGHT.PA

Price:

$0.376

Market Cap:

$39.64M

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage t...[Read more]

Industry

Biotechnology

IPO Date

2016-07-13

Stock Exchange

EURONEXT

Ticker

SIGHT.PA

The Enterprise Value as of September 2024 (TTM) for GenSight Biologics S.A. (SIGHT.PA) is 55.93M

According to GenSight Biologics S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 55.93M. This represents a change of -17.54% compared to the average of 67.82M of the last 4 quarters.

GenSight Biologics S.A. (SIGHT.PA) Historical Enterprise Value (quarterly & annually)

How has SIGHT.PA Enterprise Value performed in the past?

The mean historical Enterprise Value of GenSight Biologics S.A. over the last ten years is 108.11M. The current 55.93M Enterprise Value has changed 5.07% with respect to the historical average. Over the past ten years (40 quarters), SIGHT.PA's Enterprise Value was at its highest in in the September 2021 quarter at 314.43M. The Enterprise Value was at its lowest in in the June 2014 quarter at 0.

Quarterly (TTM)
Annual

Average

108.11M

Median

78.80M

Minimum

38.52M

Maximum

226.96M

GenSight Biologics S.A. (SIGHT.PA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GenSight Biologics S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 283.21%

Maximum Annual Enterprise Value = 226.96M

Minimum Annual Increase = -75.59%

Minimum Annual Enterprise Value = 38.52M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202338.52M-75.59%
2022157.80M-28.05%
2021219.32M-3.37%
2020226.96M283.21%
201959.23M0.94%
201858.67M-29.06%
201782.71M10.43%
201674.90M20.48%
201562.17M-38.38%
2014100.88M7.52%

GenSight Biologics S.A. (SIGHT.PA) Average Enterprise Value

How has SIGHT.PA Enterprise Value performed in the past?

The current Enterprise Value of GenSight Biologics S.A. (SIGHT.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

138.54M

5-year avg

140.36M

10-year avg

108.11M

GenSight Biologics S.A. (SIGHT.PA) Enterprise Value vs. Peers

How is SIGHT.PA’s Enterprise Value compared to its peers?

GenSight Biologics S.A.’s Enterprise Value is greater than DBV Technologies S.A. (18.15M), less than Inventiva S.A. (114.29M), greater than Quantum Genomics Société Anonyme (148.95K), less than ABIVAX Société Anonyme (445.21M), less than Nanobiotix S.A. (185.12M),

CompanyEnterprise ValueMarket cap
18.15M$69.26M
114.29M$103.80M
148.95K$979.50K
445.21M$641.69M
185.12M$209.83M

Build a custom stock screener for GenSight Biologics S.A. (SIGHT.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GenSight Biologics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GenSight Biologics S.A. (SIGHT.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GenSight Biologics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is GenSight Biologics S.A.'s Enterprise Value?

What is the highest Enterprise Value for GenSight Biologics S.A. (SIGHT.PA)?

What is the 3-year average Enterprise Value for GenSight Biologics S.A. (SIGHT.PA)?

What is the 5-year average Enterprise Value for GenSight Biologics S.A. (SIGHT.PA)?

How does the current Enterprise Value for GenSight Biologics S.A. (SIGHT.PA) compare to its historical average?